Mathew Garnett
Founder
- Senior Group Leader at the Wellcome Sanger Institute
- 20+ years’ experience in genomics and cancer therapeutics
- Developer of leading, widely-used cancer therapeutics resources (inc. DepMap and GDSC)
- Co-discoverer of:
- BRAF mutations in cancer
- Werner helicase as a target in MSI tumours
- Open Targets Sanger Scientific Lead
Show
leaders and founders
Adrian Ibrahim
Founder
Emile Voest
Founder